GlassScriptPhysician profile
Blake Beehler
NPI 1710503768
$24,164.94
in general payments reported to CMS, 2019-2025
7 companies · $4,066 in 2025
The $4,066 reported for 2025 was more than what 83% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $99.44 · 2024: $20K · 2025: $4,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $20K · Travel and Lodging: $3,100 · Food and Beverage: $966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $20,000.00 |
| Travel and Lodging | $3,099.94 |
| Food and Beverage | $965.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,716.66 | 2024-2025 | Activa PC, Percept PC Brainsense |
| Boston Scientific Corporation | $7,500.00 | 2024 | Vercise |
| Abbott Laboratories | $6,373.47 | 2024-2025 | Infinity, Proclaim |
| Insightec,INC | $1,406.84 | 2025 | Exablate |
| Biogen, INC. | $86.65 | 2022 | |
| Neurocrine Biosciences, INC. | $68.53 | 2025 | |
| Abbvie INC. | $12.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Beehler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.